Tempest Therapeutics, Inc. Restricted Cash, Noncurrent
Tempest Therapeutics, Inc. (TPST) had Restricted Cash, Noncurrent of $0 as of 2019-12-31, per its 10-K filed 2020-03-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2020-03-11
- 2019-12-31: Restricted Cash, Noncurrent $0.00.
- 2019-09-30: Restricted Cash, Noncurrent $494.00K.
- 2019-06-30: Restricted Cash, Noncurrent $658.00K.
- 2019-03-31: Restricted Cash, Noncurrent $439.00K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-11 |
| 2019-09-30 | $494.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $658.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $439.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $439.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 |
| 2018-06-30 | $789.00K 10-Q · filed 2018-08-09 |
| 2017-12-31 | $789.00K 10-Q · filed 2018-11-09 |
| 2016-12-31 | $439.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |